| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TAO Synergies Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share | 16,574 | $119,830 | $7.23 | 17 Oct 2025 | Direct |
| XWELL, Inc. | Director | Common Stock, par value $0.01 | 115,231 | $97,946 | $0.8500 | 02 Jun 2025 | Direct |
| PharmaCyte Biotech, Inc. | Director | Common Stock | 41,250 | $42,075 | $1.02 | 12 Dec 2025 | Direct |
| XWELL, Inc. | Director | Employee stock option (right to buy) | 117,886 | 02 Jun 2025 | Direct | ||
| PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 63,233 | 25 Apr 2025 | Direct | ||
| TAO Synergies Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 7,000 | 06 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TAOX | TAO Synergies Inc. | 06 Aug 2025 | 3 | -$28,920 | 4 | Chief Financial Officer | 17 Oct 2025, 17:14 |
| TAOX | TAO Synergies Inc. | 30 Jun 2025 | 2 | -$48,387 | 4 | Chief Financial Officer | 02 Jul 2025, 16:06 |
| XWEL | XWELL, Inc. | 02 Jun 2025 | 2 | $0 | 4 | Director | 03 Jun 2025, 08:01 |
| PMCB | PharmaCyte Biotech, Inc. | 25 Apr 2025 | 3 | -$34,425 | 4 | Director | 12 Dec 2025, 17:08 |
| XWEL | XWELL, Inc. | 15 Nov 2024 | 1 | $0 | 4 | Director | 18 Nov 2024, 18:37 |
| PMCB | PharmaCyte Biotech, Inc. | 30 Apr 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:59 |
| PMCB | PharmaCyte Biotech, Inc. | 20 Nov 2023 | 1 | $0 | 4 | Director | 22 Nov 2023, 17:02 |
| XWEL | XWELL, Inc. | 30 May 2023 | 1 | +$6,175 | 4 | Director | 31 May 2023, 08:32 |
| OBLG | Oblong, Inc. | 29 May 2023 | 0 | $0 | 3 | Director | 01 Jun 2023, 16:05 |
| XWEL | XWELL, Inc. | 26 May 2023 | 1 | +$6,250 | 4 | Director | 30 May 2023, 08:34 |
| XWEL | XWELL, Inc. | 05 Jan 2023 | 1 | $0 | 4/A | Director | 09 Jan 2023, 20:37 |
| SNPX | Synaptogenix, Inc. | 16 Dec 2022 | 1 | -$31,641 | 4 | Chief Financial Officer | 20 Dec 2022, 19:02 |
| SNPX | Synaptogenix, Inc. | 15 Nov 2022 | 1 | $0 | 4/A | Chief Financial Officer | 01 Dec 2022, 18:54 |
| PMCB | PharmaCyte Biotech, Inc. | 14 Nov 2022 | 0 | $0 | 3 | Director | 16 Nov 2022, 15:12 |
| XWEL | XpresSpa Group, Inc. | 20 Apr 2022 | 1 | -$47,700 | 4 | Director | 22 Apr 2022, 19:59 |
| XWEL | XpresSpa Group, Inc. | 26 Jan 2022 | 2 | $0 | 4 | Director | 31 Jan 2022, 19:19 |
| XWEL | XpresSpa Group, Inc. | 19 Jan 2022 | 1 | -$70,236 | 4 | Director | 21 Jan 2022, 16:08 |
| XWEL | XpresSpa Group, Inc. | 20 Oct 2021 | 1 | -$90,210 | 4 | Director | 22 Oct 2021, 16:15 |
| XWEL | XpresSpa Group, Inc. | 29 Jul 2021 | 1 | $0 | 4 | Director | 30 Jul 2021, 17:22 |
| SNPX | Synaptogenix, Inc. | 13 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 15 Jul 2021, 18:06 |
| SNPX | Synaptogenix, Inc. | 04 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 14 Jun 2021, 20:16 |